Product Listing

AVENIO Tumor Tissue Analysis Kits

Overview

AVENIO Tumor Tissue Analysis Kits are a portfolio of NGS assays that provide in-house tumor profiling, comprehensive genomic profiling (CGP), and surveillance & monitoring for clinical research. Through an optimized, end-to-end workflow, the kits offer a versatile solution to evaluate DNA extracted from formalin-fixed paraffin-embedded (FFPE) tissue samples.

Key Advantages of AVENIO Tumor Tissue Analysis Kits
  • Matched tissue and liquid biopsy (ctDNA) panels (same genes, gene regions and hybrid-capture workflow) for AVENIO Targeted, Expanded, and Surveillance Kits V2 to facilitate concordance analysis
  • All four mutation classes (SNVs, indels, fusions and CNVs) in a single DNA research workflow1
  • A streamlined, end-to-end research workflow from extraction to analysis and reporting in 5 days
  • An integrated solution that includes reagents, intuitive analysis and reporting to facilitate in-house adoption of high-performance NGS oncology research
Benefits of AVENIO Tumor Tissue Targeted, Expanded and Surveillance Kits:
  • Matched tissue and liquid biopsy (ctDNA) panels (same genes, gene regions and hybrid-capture workflow) for AVENIO Targeted, Expanded, and Surveillance Kits V2 to facilitate concordance analysis
  • Flexibility to switch between tissue and plasma to support a variety of research applications
Benefits of AVENIO Tumor Tissue CGP Kit
  • Designed to match the 324 gene FoundationOneĀ® CDx panel content
  • Detects genomic signatures: TMB, MSI and LOH
tumor tissue end to end workflow

References

  1. Data on file with Roche.

For Research Use Only. Not for use in diagnostic procedures.

Found 0 results in
Filters
...
    ...